How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by episodic yet cumulative heterotopic ossification (HO) of skeletal muscles, tendons, ligaments, and fascia. FOP arises from missense mutations in Activin Receptor type I (ACVR1), a type I bone morphogenetic protei...
Main Authors: | Dushyanth Srinivasan, Martin Arostegui, Erich J. Goebel, Kaitlin N. Hart, Senem Aykul, John B. Lees-Shepard, Vincent Idone, Sarah J. Hatsell, Aris N. Economides |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/14/1/101 |
Similar Items
-
Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis
by: Daniele De Brasi, et al.
Published: (2021-07-01) -
Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
by: Pignolo Robert J, et al.
Published: (2011-12-01) -
AAV-Mediated Targeting of the Activin A-ACVR1<sup>R206H</sup> Signaling in Fibrodysplasia Ossificans Progressiva
by: Yeon-Suk Yang, et al.
Published: (2023-09-01) -
Fibrodysplasia ossificans progressiva: current concepts from bench to bedside
by: Arun-Kumar Kaliya-Perumal, et al.
Published: (2020-09-01) -
Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification
by: Conan Juan, et al.
Published: (2024-03-01)